Suppr超能文献

通过嵌合配体的定量调节增强细胞类型特异性

Enhancement of cell type specificity by quantitative modulation of a chimeric ligand.

作者信息

Cironi Pablo, Swinburne Ian A, Silver Pamela A

机构信息

Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.

出版信息

J Biol Chem. 2008 Mar 28;283(13):8469-76. doi: 10.1074/jbc.M708502200. Epub 2008 Jan 29.

Abstract

Evolution modulates the quantitative characteristics of protein interactions and often uses combinations of weak interactions to achieve a particular specificity. We addressed how quantitative optimization might be used in the design of multidomain proteins, using a chimera containing epidermal growth factor (EGF) as a cell targeting element and interferon-alpha-2a (IFNalpha-2a) to initiate signal transduction. We first connected EGF and IFNalpha-2a via a linker that allows both ligands to bind to their receptors on a cell surface and then incorporated a series of mutations into the IFNalpha-2a portion that progressively decrease both the on rate and the dissociation constant of the IFNalpha-2a-IFNalpha receptor 2 (IFNAR2) interaction. Using this strategy, we designed chimeric proteins in which the activation of the IFNalpha receptor in HeLa, A431, and engineered Daudi cells depends on the presence of EGF receptor on the same cell. The mutant chimeric proteins also inhibited proliferation of IFNalpha-sensitive cells in an EGF receptor-dependent manner. These results provide insights into the quantitative requirements for specific binding to multisubunit receptors and illustrate the value of a quantitative approach in the design of synthetic-biological constructs.

摘要

进化调节蛋白质相互作用的定量特征,并且常常利用弱相互作用的组合来实现特定的特异性。我们探讨了如何在多结构域蛋白质设计中运用定量优化,采用一种嵌合体,其包含作为细胞靶向元件的表皮生长因子(EGF)和用于启动信号转导的干扰素-α-2a(IFNα-2a)。我们首先通过一个连接子将EGF和IFNα-2a连接起来,该连接子使两种配体都能在细胞表面与其受体结合,然后在IFNα-2a部分引入一系列突变,这些突变会逐渐降低IFNα-2a与IFNα受体2(IFNAR2)相互作用的结合速率和解离常数。利用这一策略,我们设计了嵌合蛋白,其中在HeLa、A431和工程化的Daudi细胞中IFNα受体的激活取决于同一细胞上EGF受体的存在。突变的嵌合蛋白还以EGF受体依赖的方式抑制了IFNα敏感细胞的增殖。这些结果为特异性结合多亚基受体的定量要求提供了见解,并说明了定量方法在合成生物学构建体设计中的价值。

相似文献

1
Enhancement of cell type specificity by quantitative modulation of a chimeric ligand.
J Biol Chem. 2008 Mar 28;283(13):8469-76. doi: 10.1074/jbc.M708502200. Epub 2008 Jan 29.
2
Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling.
J Biol Chem. 2002 Mar 22;277(12):9713-21. doi: 10.1074/jbc.M111161200. Epub 2002 Jan 10.
9
Binding specificities and affinities of egf domains for ErbB receptors.
FEBS Lett. 1999 Mar 26;447(2-3):227-31. doi: 10.1016/s0014-5793(99)00283-5.
10
Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
J Biol Chem. 2006 Dec 29;281(52):40033-40. doi: 10.1074/jbc.M603168200. Epub 2006 Oct 10.

引用本文的文献

1
BRAIDing receptors for cell-specific targeting.
Elife. 2024 Jan 9;12:RP90221. doi: 10.7554/eLife.90221.
2
Bioinspired Design of Artificial Signaling Systems.
Biochemistry. 2023 Jan 17;62(2):178-186. doi: 10.1021/acs.biochem.2c00368. Epub 2022 Aug 19.
3
General principles of binding between cell surface receptors and multi-specific ligands: A computational study.
PLoS Comput Biol. 2017 Oct 10;13(10):e1005805. doi: 10.1371/journal.pcbi.1005805. eCollection 2017 Oct.
4
Targeted erythropoietin selectively stimulates red blood cell expansion in vivo.
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5245-50. doi: 10.1073/pnas.1525388113. Epub 2016 Apr 25.
5
Synergistic interaction between selective drugs in cell populations models.
PLoS One. 2015 Feb 11;10(2):e0117558. doi: 10.1371/journal.pone.0117558. eCollection 2015.
8
Synthetic biology in mammalian cells: next generation research tools and therapeutics.
Nat Rev Mol Cell Biol. 2014 Feb;15(2):95-107. doi: 10.1038/nrm3738. Epub 2014 Jan 17.
9
A tunable coarse-grained model for ligand-receptor interaction.
PLoS Comput Biol. 2013;9(11):e1003274. doi: 10.1371/journal.pcbi.1003274. Epub 2013 Nov 14.
10
A mathematical model for the rational design of chimeric ligands in selective drug therapies.
CPT Pharmacometrics Syst Pharmacol. 2013 Feb 13;2(2):e26. doi: 10.1038/psp.2013.2.

本文引用的文献

2
Mechanisms of type-I- and type-II-interferon-mediated signalling.
Nat Rev Immunol. 2005 May;5(5):375-86. doi: 10.1038/nri1604.
3
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.
Cancer Cell. 2004 Apr;5(4):317-28. doi: 10.1016/s1535-6108(04)00083-2.
7
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.
Nature. 2003 Feb 13;421(6924):756-60. doi: 10.1038/nature01392.
8
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Cell. 2002 Sep 20;110(6):775-87. doi: 10.1016/s0092-8674(02)00963-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验